| Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants LSL Ting, E Villeneuve, MHH Ensom Therapeutic drug monitoring 28 (3), 419-430, 2006 | 148 | 2006 |
| Andexanet Alfa for Factor Xa Inhibitor Reversal. JJ Wang, S Gosselin, E Villeneuve The New England journal of medicine 375 (25), 2498-2498, 2016 | 34* | 2016 |
| Massive acetaminophen overdose: effect of hemodialysis on acetaminophen and acetylcysteine kinetics M Ghannoum, S Kazim, AM Grunbaum, E Villeneuve, S Gosselin Clinical Toxicology 54 (6), 519-522, 2016 | 31 | 2016 |
| Clinical pharmacy services in Canadian emergency departments: a national survey R Wanbon, C Lyder, E Villeneuve, S Shalansky, L Manuel, M Harding The Canadian journal of hospital pharmacy 68 (3), 191, 2015 | 27 | 2015 |
| Intraosseous administration of antidotes–a systematic review A Elliott, PA Dubé, A Cossette-Côté, L Patakfalvi, E Villeneuve, M Morris, ... Clinical Toxicology, 1-30, 2017 | 16 | 2017 |
| Medication reconciliation practices in Canadian emergency departments: a national survey R Wanbon, C Lyder, E Villeneuve, S Shalansky, L Manuel, M Harding The Canadian journal of hospital pharmacy 68 (3), 202, 2015 | 14 | 2015 |
| Four-hour acetaminophen concentration estimation after ingested dose based on pharmacokinetic models E Villeneuve, S Gosselin, I Whyte Clinical toxicology 52 (5), 556-560, 2014 | 7 | 2014 |
| Doubling the third dose of intravenous N-acetylcysteine survey: An international practice perspective S Al Juma, E Villeneuve, A Elliot, RB Palmer, S Gosselin CLINICAL TOXICOLOGY 53 (4), 253-254, 2015 | 6 | 2015 |
| Acetaminophen and N-acetylcysteine dialysance during hemodialysis for massive ingestion AM Grunbaum, S Kazim, M Ghannoum, MA Kallai-Sanfacon, R Mangel, ... Clinical Toxicology 51 (4), 270-271, 2013 | 6 | 2013 |
| Are Recommended Doses of Acetaminophen Effective for Children Aged 2 to 3 Years? A Pharmacokinetic Modeling Answer DA Abourbih, S Gosselin, E Villeneuve, S Kazim Pediatric emergency care 32 (1), 6-8, 2016 | 5 | 2016 |
| Cannabinoid hyperemesis syndrome and topical capsaicin: treating smoke with fire? JJ Wang, E Villeneuve, JA Amiel, S Gosselin Clinical toxicology (Philadelphia, Pa.), 1, 2017 | 2 | 2017 |
| There is No Contraindication to Emergent Glucose Administration E Villeneuve, S Gosselin, RS Hoffman Annals of emergency medicine 69 (3), 376-377, 2017 | 2 | 2017 |
| In Response to:“The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty” J Lombardi, E Villeneuve, S Gosselin Journal of Medical Toxicology 12 (4), 412-413, 2016 | 2 | 2016 |
| Intubation and salicylate overdose S Gosselin, JJ Wang, E Villeneuve, D Juurlink, RS Hoffman The American Journal of Emergency Medicine, 2017 | 1 | 2017 |
| Letter in response to" Idarucizumab for dabigatran overdose". JJ Wang, E Villeneuve, S Gosselin Clinical toxicology (Philadelphia, Pa.) 55 (1), 65, 2017 | 1 | 2017 |
| Letter in response to" Lithium poisoning in the intensive care unit: predictive factors of severity and indications for extracorporeal toxin removal to improve outcome". E Villeneuve, JJ Wang, AM Grunbaum, S Gosselin Clinical toxicology (Philadelphia, Pa.) 55 (1), 67-68, 2017 | 1 | 2017 |
| Balancing the risks and benefits of medication organizers: reply to Wang et al. S Davis, J Wang, E Villeneuve, M Persson, JA Amiel, S Gosselin Clinical Toxicology, 1-1, 2017 | | 2017 |
| Balancing the publication bias: 45 cases of failed lipid rescue SC Smolinske, E Villeneuve, RS Hoffman, S Gosselin CLINICAL TOXICOLOGY 55 (5), 392-392, 2017 | | 2017 |
| Energy drink consumption patterns and knowledge of adverse effects amongst medical students, pharmacy students, pharmacists and residents in Quebec, Canada A Doucet, E Villeneuve, S Gosselin CLINICAL TOXICOLOGY 55 (5), 491-492, 2017 | | 2017 |
| Management of a mixed overdose in the prehospital setting: a case report E Villeneuve, MS Delisle, JJ Wang, S Gosselin Clinical Toxicology 55 (5), 511-511, 2017 | | 2017 |
